Combining CD39 & CD73 Inhibition for Treatment of Pancreatic Cancer

Time: 2:15 pm
day: Day One

Details:

• Discussing non-redundant functions of CD39 and CD73 in PDAC

• Presenting data to reveal novel mechanisms-of-action

Speakers: